Financial giants have made a conspicuous bullish move on Merck & Co. Our analysis of options history for Merck & Co MRK revealed 11 unusual trades.
Delving into the details, we found 63% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $345,354, and 5 were calls, valued at $202,967.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $130.0 for Merck & Co during the past quarter.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Merck & Co's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Merck & Co's whale activity within a strike price range from $85.0 to $130.0 in the last 30 days.
Merck & Co 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | PUT | TRADE | BULLISH | 01/16/26 | $18.75 | $18.1 | $18.25 | $130.00 | $182.5K | 332 | 100 |
| MRK | CALL | SWEEP | BULLISH | 09/06/24 | $1.99 | $1.98 | $1.99 | $116.00 | $49.9K | 180 | 327 |
| MRK | CALL | SWEEP | BULLISH | 01/17/25 | $8.15 | $8.05 | $8.15 | $115.00 | $40.7K | 2.1K | 50 |
| MRK | CALL | SWEEP | BEARISH | 10/18/24 | $1.86 | $1.8 | $1.81 | $120.00 | $39.8K | 12.6K | 635 |
| MRK | CALL | SWEEP | BULLISH | 09/06/24 | $1.97 | $1.96 | $1.97 | $116.00 | $37.8K | 180 | 520 |
About Merck & Co
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
In light of the recent options history for Merck & Co, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Merck & Co
- With a trading volume of 3,209,934, the price of MRK is down by -0.19%, reaching $116.38.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 59 days from now.
Professional Analyst Ratings for Merck & Co
In the last month, 4 experts released ratings on this stock with an average target price of $138.5.
- Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Merck & Co with a target price of $145.
- Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Merck & Co, targeting a price of $142.
- An analyst from Wells Fargo persists with their Equal-Weight rating on Merck & Co, maintaining a target price of $125.
- An analyst from UBS has decided to maintain their Buy rating on Merck & Co, which currently sits at a price target of $142.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck & Co options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
